Possibilities of application of regenerative technologies in gynecology
article
OA: hybrid
CC0
Abstract
The article presents a review of publications devoted to the use of regenerative technologies in the treatment of gynecological pathologies. The authors describe possible ways to solve these problems by analyzing the experimental studies conducted in the world. Identified the main indications for tissue engineering: Ashermans syndrome, primary ovarian failure, infertility caused by chemotherapy, a niche in the uterus, endometrial pathology (endometriosis, endometrial problems, etc.), cervical pathology, female genital tract abnormalities, pelvic organ prolapse. The results of clinical trials of cell therapy aimed at treating infertility caused by Asherman syndrome and primary ovarian failure, female genital tract abnormalities, as well as such rare pathology as a niche of the uterus. At the preclinical stage, in addition to the above, considered cellular therapy of cervical pathologies, endometrial diseases and pelvic organ prolapse. Eximined cell cultures and the level of their influence on the regeneration of the female reproductive system structures, presented the biological scaffolds that stimulate the growth of stem cells, their effectiveness and shortcomings are covered.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (65)
- Regeneration of uterine horns in rats by collagen scaffolds loaded with collagen-binding human basic fibroblast growth factor via openalex
- W1537184539 via openalex
- W1574633098 via openalex
- W1580771990 via openalex
- W1869117700 via openalex
- W1937647947 via openalex
- W1964554602 via openalex
- W1964907874 via openalex
- W1970201694 via openalex
- W1973878648 via openalex
- W1981885698 via openalex
- W1986658801 via openalex
- W1986735604 via openalex
- W1987125576 via openalex
- W1991653488 via openalex
- W1996890527 via openalex
- W2008243921 via openalex
- W2010899501 via openalex
- W2015465021 via openalex
- W2022955538 via openalex
- W2036386857 via openalex
- W2043509357 via openalex
- W2046663172 via openalex
- W2049516578 via openalex
- W2052144873 via openalex
- W2053347930 via openalex
- W2060831202 via openalex
- W2062895932 via openalex
- W2066216354 via openalex
- W2068881657 via openalex
- W2073139339 via openalex
- W2080856952 via openalex
- W2081100505 via openalex
- W2089362068 via openalex
- W2101540302 via openalex
- W2115701515 via openalex
- W2136638400 via openalex
- W2160715802 via openalex
- W2163041776 via openalex
- W2165735772 via openalex
- W2166623676 via openalex
- W2308714122 via openalex
- W2313746835 via openalex
- W2334540077 via openalex
- W2514216329 via openalex
- W2591692261 via openalex
- W2593036422 via openalex
- W2595655381 via openalex
- W2602426876 via openalex
- W2605949967 via openalex
- W2611957270 via openalex
- W2626882866 via openalex
- W2748312114 via openalex
- W2759674016 via openalex
- W2766156193 via openalex
- W2768992437 via openalex
- W2770353972 via openalex
- W2781830558 via openalex
- W2790246036 via openalex
- W2793503723 via openalex
- W2805438999 via openalex
- W2810583348 via openalex
- W2896986972 via openalex
- W174324520 via openalex
- W4245808756 via openalex
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0
· commercial use OK